Date: March 1, 2018
FosRich Company Limited (FOSRICH) for the twelve months ended December 31, 2017 booked a 9% decrease in revenue to total $1.05 billion compared to $1.16 billion for the same period in 2016.
Cost of sales for the year showed a reduction of 17%, moving from $686.66 million to $573.01 million. Despite this decrease, gross profit amounted to $473.23 million, an increase of 1% when compared to $468.89 million recorded last year.
Other income, for the year totalled $41.91 million a significant increase when compared to the $12.88 million recorded for the prior financial year.
Administrative and other expenses climbed by 5%, to total $404.83 million (2016: $384.30 million). Finance costs of $51.43 million were recorded for the year, an decline of 17% when compared to $62.19 million in the year prior.
Profit before taxation totalled $58.88 million compared to $35.29 million last year. The company booked tax charges for the period of $3.94 million (2016: $4.95 million).
Net Profit for the year totalled $54.94 million, an 81% increase compared to $30.34 million the prior financial year.
Earnings per share (EPS) for the year totalled $0.11 (2016: $0.06). The number of share used in our calculations amounted to 502,275,555 units. FOSRICH’s stock price close the trading period on March 1, 2017 at $2.67.
Balance Sheet at a glance:
As at December 31, 2017, total assets amounted to $1.30 billion, up $178.57 million from the balance of $1.12 billion as at December 2016. The increase in total assets was as a result of the Short-term Loan and ‘Due from Related Parties’ which totalled $103.74 million (2016: nil) and $124.97 million (2016: $67.06 million).
Shareholders’ Equity of $608.97 million was reported (2016: $398.91 million) which resulted in a book value per share of $1.21 (2016: $0.79).
Analyst Certification -This research report is for information purposes only and should not be construed as a recommendation. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report.
Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.